Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-28 @ 6:02 PM
Study NCT ID:
NCT01391403
Status:
COMPLETED
Last Update Posted:
2016-07-12
First Post:
2011-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
Sponsor:
Beijing HuiLongGuan Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SMRI 05T-726
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |